Global Narcolepsy Drugs Market
Global Narcolepsy Drugs Market Report 2024-2032: Therapeutic Types, Disease Types, End Users, Countries, and Company Analysis Featuring Jazz Pharmaceuticals, Ligand Pharmaceuticals, Novartis, and More
30 juil. 2024 08h01 HE | Research and Markets
Dublin, July 30, 2024 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market Report by Therapeutic Type Disease Type End Users Countries and Company Analysis, 2024-2032" report has been added to ...
22157.jpg
Autistic Disorder Pipeline Insight Report 2024, Featuring Key Products Tasimelteon, Cariprazine, L1-79, JZP541, AB-2004, RO6953958 and SB-121
22 avr. 2024 11h10 HE | Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Autistic Disorder - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...
22157.jpg
Narcolepsy Drugs Industry Outlook to 2030: Emphasizing Growth in the Sodium Oxybate and Central Nervous System Stimulants Segments
24 janv. 2024 14h35 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent...
Global Narcolepsy Drugs Market
Sodium Oxybate Takes Center Stage in Narcolepsy Treatment: Key Player in $5.95 Billion Narcolepsy Drugs Industry by 2030
07 nov. 2023 06h48 HE | Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...
Reports Insights Logo.jpg
Panic Disorder Market Towards US$ 12,621.61 Mn By 2030, A Comprehensive Analysis By Reports Insights
29 mai 2023 05h00 HE | REPORTSINSIGHTS CONSULTING PVT LTD
New York, May 29, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Reports Insights, the panic disorder market is poised for strong expansion and is expected to reach USD  12,621.61 Million...
Global Acute Migraine Drugs Market
Global Acute Migraine Drugs Market Report 2023: A $14.06 Billion Market by 2028 Featuring Key Players - Eli Lilly and Co, GSK, Bayer, J&J, Teva, AbbVie, Novartis, Merck, Pfizer, & Boehringer Ingelheim
10 mars 2023 05h53 HE | Research and Markets
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By...
Global Market for Narcolepsy Therapeutics
The Worldwide Narcolepsy Therapeutics Industry is Projected to Reach $3.6 Billion by 2030 at a CAGR of 7.3%
16 févr. 2023 11h33 HE | Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Narcolepsy...
22157.jpg
Autism Spectrum Disorder Treatment Global Market Report 2022: Sector to Grow by 6.47% Annually Through 2033
29 déc. 2022 07h08 HE | Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Autism Spectrum Disorder Treatment Market by Treatment, Application, Distribution Channel, and by Region - Global Forecast to 2022-2033" report has...
narcolepsy-therapeutics-market-size.jpg
Global Narcolepsy Therapeutics Market Report to 2028: Growing Healthcare Expenditures and Increasing Prevalence of Neurological Conditions are Driving Factors
10 nov. 2022 07h08 HE | Research and Markets
Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin...
Global Narcolepsy Drugs Market
Global Narcolepsy Drugs Market Report 2022 - Sodium Oxybate Dominates, Owing to Its Dual-Pronged Approach in Treating Daytime Extreme Sleepless and Cataplexy
28 févr. 2022 05h28 HE | Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been...